Exploring novel cell sources to overcome limitations in current modalities

Advanced therapies rely on consistent, high-quality cell sources to achieve reproducible outcomes. This session highlights emerging cell types, sourcing strategies, and process adaptations that address current modality limitations while supporting scalable production and broader clinical application. 

Key takeaways 

• Identify novel cell sources that expand therapeutic potential 

• Explore methods to improve scalability and reproducibility 

• Discuss strategies to maintain product quality and functional integrity 

• Evaluate process adaptations for integrating alternative cell types 

• Review examples demonstrating practical implementation in advanced therapy workflows